Philippines to Roll Out 15,000 Doses of Six-Month HIV Prevention Injection as New National Prevention Push Expands

 

The Philippines is preparing to introduce a significant expansion in its HIV prevention strategy with the arrival of approximately 15,000 doses of a new long-acting injectable treatment designed to reduce the risk of infection.

The drug, lenacapavir, is a form of pre-exposure prophylaxis administered only twice a year. Its extended protection window marks a major shift from traditional daily oral prevention methods, offering a more streamlined option for individuals who are at risk but currently free from HIV/AIDS.

Distribution will be carried out through select health facilities nationwide, including treatment hubs and both public and private clinics. The program is being coordinated by the Department of Health under its national HIV and STI prevention framework.

Health officials emphasize that the injectable is intended for individuals who test non-reactive, serving as a preventive barrier rather than a treatment. In practical terms, it strengthens the country’s preventive arsenal by lowering the probability of viral transmission before exposure occurs.

The rollout was made possible through collaboration between the Department of Health and the United States Department of State, which facilitated the donation of the supply.

From a public health perspective, the introduction of a twice-yearly injectable can be compared to setting up a long-duration protective shield instead of relying on daily maintenance. This approach is expected to improve adherence, particularly among populations that face challenges with consistent medication schedules.

The urgency of expanded prevention efforts is underscored by recent surveillance data. From January to March alone, 4,633 new HIV/AIDS cases were recorded nationwide. Since 1984, the cumulative number of confirmed infections has reached 168,079.

Health authorities view the new injectable option as a critical addition to existing prevention tools, particularly as the country continues to confront sustained transmission levels.